Canada markets open in 2 hours 26 minutes

Apellis Pharmaceuticals, Inc. (APLS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
47.51-0.52 (-1.08%)
At close: 04:00PM EDT
49.30 +1.79 (+3.77%)
Pre-Market: 04:23AM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
396,591
396,591
75,422
66,563
250,646
Cost of Revenue
58,510
58,510
5,636
5,200
25,050
Gross Profit
338,081
338,081
69,786
61,363
225,596
Operating Expenses
Research Development
354,387
354,387
387,236
420,869
299,921
Selling General and Administrative
500,815
500,815
277,163
176,771
139,401
Total Operating Expenses
855,202
855,202
664,399
597,640
439,322
Operating Income or Loss
-517,121
-517,121
-594,613
-536,277
-213,726
Interest Expense
29,581
29,581
32,626
13,241
29,937
Total Other Income/Expenses Net
-727
-727
-33,178
-196,902
-103,530
Income Before Tax
-526,496
-526,496
-651,503
-746,002
-343,029
Income Tax Expense
2,132
2,132
669
352
1,845
Income from Continuing Operations
-528,628
-528,628
-652,172
-746,354
-344,874
Net Income
-528,628
-528,628
-652,172
-746,354
-344,874
Net Income available to common shareholders
-528,628
-528,628
-652,172
-746,354
-344,874
Basic EPS
-5.23
-4.45
-6.15
-8.84
-4.59
Diluted EPS
-5.23
-4.45
-6.15
-8.84
-4.59
Basic Average Shares
116,028
118,678
106,114
84,421
75,163
Diluted Average Shares
116,028
118,678
106,114
84,421
75,163